ALK and anaplastic large cell lymphoma: Crizotinib was shown to decrease autophagic flux in ALK+ ALCL, which was important for tumor survival of NPM–ALK+ ALCL; this cytoprotective response reduced the cytotoxicity of crizotinib (56, 74).